Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in 470 Argentinean patients

被引：0
|
作者：
Belli, C. [1 ]
Bestach, Y. [2 ]
Bengio, R. [3 ]
Sakamoto, F. [4 ]
Nucifora, E. [5 ]
Gonzalez, J. [6 ]
Crisp, R. [7 ]
Fazio, P. [8 ]
Pintos, N. [9 ]
Larripa, I. [10 ]
机构：
[1] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med Grp Estudio SMD, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
[3] IIHEMA ANM, Med Clin, Buenos Aires, DF, Argentina
[4] Privado Hematol & Hemoterapia, Hematol, Parana, Argentina
[5] Hosp Italiano Buenos Aires, Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[6] HIGA C Durand Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[7] Hosp A Posadas Grp Estudio SMD, Hematol, El Palomar, Argentina
[8] HIGA San Martin Grp Estudio SMD, Hematol, La Plata, Argentina
[9] Sanatorio Julio Mendez Grp Estudio SMD, Hematol, Buenos Aires, DF, Argentina
[10] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, IMEX, Genet Hematol, RA-1033 Buenos Aires, DF, Argentina
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70156-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-108
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [41] Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
    Wan-Hsuan Lee
    Ming-Tao Tsai
    Cheng-Hong Tsai
    Feng-Ming Tien
    Min-Yen Lo
    Mei-Hsuan Tseng
    Yuan-Yeh Kuo
    Ming-Chih Liu
    Yi-Tsung Yang
    Jui-Che Chen
    Jih-Luh Tang
    Hsun-I Sun
    Yi-Kuang Chuang
    Liang-In Lin
    Wen-Chien Chou
    Chien-Chin Lin
    Hsin-An Hou
    Hwei-Fang Tien
    Blood Cancer Journal, 13
  • [42] Validating the Lower-Risk MD Anderson Prognostic Scoring System (LR-PSS) and the Revised International Prognostic Scoring System (IPSS-R) for Patients with Myelodysplastic Syndromes
    Sekeres, Mikkael A.
    Elson, Paul
    Tiu, Ramon V.
    Saunthararajah, Yogen
    Advani, Anjali S.
    Paulic, Katarina
    Chan, Josephine
    Pierce, Sherry
    Jabbour, Elias
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    Garcia-Manero, Guillermo
    BLOOD, 2011, 118 (21) : 749 - 750
  • [43] Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System
    Arnan, Montserrat
    Pomares, Helena
    Sanchez-Ortega, Isabel
    Alonso, Ester
    Condom, Maria
    Encuentra, Maite
    Grau, Javier
    Sureda, Anna
    BLOOD, 2016, 128 (22)
  • [44] The Revised International Prognostic Scoring System "Molecular" (IPSS-Rm), a Validated and Dynamic Model in Treated Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Narkhede, Mayur Subhash
    Radivoyevitch, Tomas
    Kalaycio, Matt
    Patel, Bhumika J.
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Clemente, Michael
    Hirsch, Cassandra M.
    Advani, Anjali S.
    Przychodzen, Bartlomiej
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [45] International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS).
    Balduini, CL
    Guarnone, R
    Pecci, A
    Centenara, E
    BLOOD, 1997, 90 (10) : 4026 - 4026
  • [46] Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms
    Polprasert, Chantana
    Niparuck, Pimjai
    Rattanathammethee, Thanawat
    Kobbuaklee, Sirorat
    Lanamtieng, Theerin
    Rojnuckarin, Ponlapat
    HEMATOLOGY, 2022, 27 (01) : 1294 - 1297
  • [47] CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
    Pease, D.
    Ross, J.
    Poynter, J.
    Nguyen, P.
    Hirsch, B.
    Cioc, A.
    Roesler, M.
    Warlick, E.
    LEUKEMIA RESEARCH, 2015, 39 : S118 - S118
  • [48] Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms
    Yang, Tingting
    Jiang, Binqian
    Luo, Yi
    Zhao, Yanmin
    Ouyang, Guifang
    Yu, Jian
    Lan, Jianping
    Lu, Ying
    Lai, Xiaoyu
    Ye, Baodong
    Chen, Yi
    Liu, Lizhen
    Xu, Yang
    Shi, Pengfei
    Xiao, Haowen
    Hu, Huixian
    Guo, Qunyi
    Fu, Huarui
    Ye, Yishan
    Wang, Xinyu
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Shi, Jimin
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : E391 - E394
  • [49] Additional prognostic value of bone marrow histology in patients subclassified according to the international prognostic scoring system for myelodysplastic syndromes
    Verburgh, E
    Achten, R
    Maes, B
    Hagemeijer, A
    Boogaerts, M
    De Wolf-Peeters, C
    Verhoef, G
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 273 - 282
  • [50] MYELODYSPLASTIC SYNDROMES - A SCORING SYSTEM WITH PROGNOSTIC-SIGNIFICANCE
    MUFTI, GJ
    STEVENS, JR
    OSCIER, DG
    HAMBLIN, TJ
    MACHIN, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (03) : 425 - 433
12345